Uprosertib (GSK2141795) is a selective, ATP-competitive, and orally bioavailable Akt inhibitor with IC50 of 180 nM, 328 nM, and 38 nM for Akt 1, 2 and 3, respectively
For research use only. We do not sell to patients.
Name | Uprosertib (GSK2141795) |
---|---|
Iupac Chemical Name | 2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)- |
Synonyms | GSK795 |
Molecular Formula | C18H16Cl2F2N4O2 |
Molecular Weight | 429.25 |
Smile | NC[C@H](CC1=CC(=C(C=C1)F)F)NC(=O)C=1OC(=C(C1)C1=C(C=NN1C)Cl)Cl |
InChiKey | AXTAPYRUEKNRBA-JTQLQIEISA-N |
InChi | InChI=1S/C18H16Cl2F2N4O2/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1 |
CAS Number | 1047634-65-0 |
Related CAS |
Packaging | Price | Availability | Purity | Shipping Time |
---|---|---|---|---|
Bulk | Enquiry | Enquiry | Enquiry |
Formulation | Solid powder |
---|---|
Purity | 98% by HPLC |
Storage | -20 ºC for 3 years |
Solubility | Soluble in DMSO |
Handling | |
Shipping Condition | Shipped under ambient temperature |
HS Code |
Targets | |
---|---|
Mechanism | |
Cell study | |
Animal study | |
Clinical study |